Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot”

• Sharon E. Johnatty ,

  Contributed equally to this work with: Sharon E. Johnatty, Jonathan Beesley

  * E-mail: sharonJo@qimr.edu.au

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Jonathan Beesley ,

  Contributed equally to this work with: Sharon E. Johnatty, Jonathan Beesley

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Xiaoqing Chen,

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Stuart Macgregor,

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• David L. Duffy,

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Amanda B. Spurdle,

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Anna deFazio,

  Affiliation Department of Gynaecological Oncology and Westmead Institute for Cancer Research, University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia

  ⨯
• Natalie Gava,

  Affiliation Department of Gynaecological Oncology and Westmead Institute for Cancer Research, University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia

  ⨯
• Penelope M. Webb,

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Australian Ovarian Cancer Study Group,

  Affiliations Queensland Institute of Medical Research, Brisbane, Australia, Department of Gynaecological Oncology and Westmead Institute for Cancer Research, University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia, Peter MacCallum Cancer Centre, East Melbourne, Australia

  ⨯
• Australian Cancer Study (Ovarian Cancer),

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Mary Anne Rossing,

  Affiliation Epidemiology Program, Division of Public Health Services, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Jennifer Anne Doherty,

  Affiliation Epidemiology Program, Division of Public Health Services, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Marc T. Goodman,

  Affiliation Cancer Research Center of Hawaii, University of Hawaii, Hilo, Hawaii, United States of America

  ⨯
• Galina Lurie,

  Affiliation Cancer Research Center of Hawaii, University of Hawaii, Hilo, Hawaii, United States of America

  ⨯
• Pamela J. Thompson,

  Affiliation Cancer Research Center of Hawaii, University of Hawaii, Hilo, Hawaii, United States of America

  ⨯
• Lynne R. Wilkens,

  Affiliation Cancer Research Center of Hawaii, University of Hawaii, Hilo, Hawaii, United States of America

  ⨯
• Roberta B. Ness,

  Affiliation University of Texas School of Public Health, Houston, Texas, United States of America

  ⨯
• Kirsten B. Moysich,

  Affiliation Roswell Park Cancer Center, Buffalo, New York, United States of America

  ⨯
• Jenny Chang-Claude,

  Affiliation Unit of Genetic Epidemiology, Division of Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany

  ⨯
• Shan Wang-Gohrke,

  Affiliation Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany

  ⨯
• Daniel W. Cramer,

  Affiliation Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Kathryn L. Terry,

  Affiliation Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Susan E. Hankinson,

  Affiliations Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Shelley S. Tworoger,

  Affiliations Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Montserrat Garcia-Closas,

  Affiliation National Cancer Institute, Division of Cancer Epidemiology and Genetics, Rockville, Maryland, United States of America

  ⨯
• Hannah Yang,

  Affiliation National Cancer Institute, Division of Cancer Epidemiology and Genetics, Rockville, Maryland, United States of America

  ⨯
• Jolanta Lissowska,

  Affiliation Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland

  ⨯
• Stephen J. Chanock,

  Affiliation Laboratory of Translational Genomics Division of Cancer Epidemiology and Genetics National Cancer Institute and Core Genotyping Facility Division of Cancer Epidemiology and Genetics National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Paul D. Pharoah,

  Affiliation Department of Oncology and Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Honglin Song,

  Affiliation Department of Oncology and Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Alice S. Whitemore,

  Affiliation Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Celeste L. Pearce,

  Affiliation Department of Preventative Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Daniel O. Stram,

  Affiliation Department of Preventative Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Anna H. Wu,

  Affiliation Department of Preventative Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Malcolm C. Pike,

  Affiliation Department of Preventative Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Simon A. Gayther,

  Affiliation Department of Gynaecological Oncology, UCL EGA Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Susan J. Ramus,

  Affiliation Department of Gynaecological Oncology, UCL EGA Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Usha Menon,

  Affiliation Department of Gynaecological Oncology, UCL EGA Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Aleksandra Gentry-Maharaj,

  Affiliation Department of Gynaecological Oncology, UCL EGA Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Hoda Anton-Culver,

  Affiliation Department of Epidemiology, School of Medicine, University of California Irvine, Irvine, California, United States of America

  ⨯
• Argyrios Ziogas,

  Affiliation Department of Epidemiology, School of Medicine, University of California Irvine, Irvine, California, United States of America

  ⨯
• Estrid Hogdall,

  Affiliation Department of Virus, Hormones, and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark

  ⨯
• Susanne K. Kjaer,

  Affiliations Department of Virus, Hormones, and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark, Gynaecologic Clinic, The Juliane Marie Centre, Righosptalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Claus Hogdall,

  Affiliation Gynaecologic Clinic, The Juliane Marie Centre, Righosptalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Andrew Berchuck,

  Affiliation Division of Preventative Medicine, The Duke Comprehensive Cancer Center, Durham, North Carolina, United States of America

  ⨯
• Joellen M. Schildkraut,

  Affiliation Division of Preventative Medicine, The Duke Comprehensive Cancer Center, Durham, North Carolina, United States of America

  ⨯
• Edwin S. Iversen,

  Affiliation Division of Preventative Medicine, The Duke Comprehensive Cancer Center, Durham, North Carolina, United States of America

  ⨯
• Patricia G. Moorman,

  Affiliation Division of Preventative Medicine, The Duke Comprehensive Cancer Center, Durham, North Carolina, United States of America

  ⨯
• Catherine M. Phelan,

  Affiliation Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center and Research Institute, Magnolia Drive, Tampa, Florida, United States of America

  ⨯
• Thomas A. Sellers,

  Affiliation Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center and Research Institute, Magnolia Drive, Tampa, Florida, United States of America

  ⨯
• Julie M. Cunningham,

  Affiliation Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Robert A. Vierkant,

  Affiliation Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• David N. Rider,

  Affiliation Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Ellen L. Goode,

  Affiliation Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Izhak Haviv,

  Affiliations The Blood and DNA Profiling Facility, Baker IDI, Melbourne, Australia, Department of Biochemistry, School of Medicine, University of Melbourne, Parkville, Australia

  ⨯
• Georgia Chenevix-Trench,

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
•  [ ... ],
• Ovarian Cancer Association Consortium

  ¶Membership of the Ovarian Cancer Association Consortium is provided in the Acknowledgments.

  ⨯
• [ view all ]
• [ view less ]